Can Suzano (SUZ) Stock Reach $13.20?

Key Takeaways

• The central target of $13.20 is the arithmetic mean of two current U.S.-listed analyst price targets: $13.00 from Bank of America and $13.40 from Jefferies.
• With the shares near $8.45, reaching $13.20 would require a gain of roughly 56% — a very large move by any standard.
• Aggregators report a narrow $13.00–$13.40 target band, though broader data vendors show a wider spread from about $10.39 to $14.50.
• The strongest supports are a recovering pulp price, a low-cost production position, and the new Arbex tissue joint venture with Kimberly-Clark.
• The biggest risks are elevated leverage, declining earnings estimates, and exposure to the Brazilian real and the global pulp cycle.

Analyst Price Targets and Consensus View

Suzano S.A. (SUZ), the world's largest producer of hardwood eucalyptus pulp, has relatively thin dedicated coverage on its U.S.-listed American Depositary Shares. Two clearly attributable, current price targets were verified. Bank of America's Caio Ribeiro upgraded the ADR to Buy from Neutral in August 2026 with a target of $13.00, up from $10.00, arguing that earnings momentum should turn positive as pulp prices bottom. Jefferies' Francisco Barbosa initiated coverage in February 2026 with a Buy and a $13.40 target. The average of those two targets is $13.20, which MarketBeat independently lists as its four-analyst average, with a $13.00–$13.40 range.

Broader Brazilian sell-side coverage exists on the company's Brazil-listed shares, but those targets are denominated in Brazilian reais and are not directly comparable to the ADR. The overall picture is cautiously constructive: ratings skew toward Buy or Outperform, but the number of U.S. targets is small, so the "consensus" is best read as directional rather than precise.

Current Market Position and Path Toward the Target

The ADR traded near $8.45 in mid-October 2026, roughly 56% below the $13.20 central target. That is a very large required move, and it would take the shares back above their 52-week high of about $11.54. The stock has drifted lower from above $9.50 in late September, reflecting pressure on earnings estimates even as pulp prices have begun to recover.

A path to the target would most likely depend on a sustained upcycle in pulp pricing, operating leverage on Suzano's low-cost production base, and progress deleveraging the balance sheet after the July 2026 completion of the Arbex tissue joint venture. Reaching $13.20 implies meaningful multiple expansion as well as earnings recovery, because forward estimates currently point to earnings per share (EPS) declining through 2027.

What Could Support a Move Toward the Target

• Pulp-price recovery: Suzano announced a second consecutive price increase — $50 per ton in the Americas and Europe and $20 per ton in Asia, effective October 1 — which analysts such as Bank of America read as evidence the cycle trough may be behind the company.
• Cost leadership: Suzano is among the world's lowest-cost pulp producers, giving it strong operating leverage when realized prices rise.
• Attractive valuation: The ADR trades at a trailing price-to-earnings (P/E) ratio around 6.6 and a forward P/E near 5.7, well below typical market multiples.
• Arbex integration: The 51%-owned joint venture with Kimberly-Clark, which launched in July 2026, diversifies revenue into higher-margin consumer tissue and hygiene products across more than 70 markets.

What Could Prevent the Target From Being Reached

• Commodity-cycle risk: Hardwood pulp is globally priced and cyclical; a stall or reversal in the recent price increases would directly pressure revenue and EBITDA (earnings before interest, taxes, depreciation, and amortization).
• Elevated leverage: Management has flagged deleveraging as its top priority, with leverage near 3.2–3.3 times EBITDA after heavy capital spending and working-capital outflows.
• Currency and macro exposure: A stronger Brazilian real or softer global demand — especially from China, the key pulp market — can compress dollar-denominated results.
• Declining estimates: Consensus EPS is forecast to fall from around $1.46 in 2026 to near $1.07 in 2027, which historically has weighed on the multiple investors are willing to pay.

Technical Levels and Market Structure

The ADR sits below both its 50-day moving average near $8.73 and its 200-day moving average near $9.06, indicating a near-term downtrend. Durable support sits around the 52-week low of $7.55–$7.56. On the upside, the $9.00–$9.50 zone represents prior congestion and a likely resistance level, while the 52-week high near $11.54 is the next major structural hurdle before the $13.20 target. In other words, the stock would need to break a descending trend and retake two meaningful resistance zones to approach the target.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a roughly 12-month research horizon, though individual assumptions on pulp prices and the Brazilian real vary widely. Because coverage of the ADR is thin, the central target should be treated with extra caution. Key items to watch include the quarterly earnings report scheduled for November 5, 2026, any further pulp-price announcements, management commentary on leverage and the Arbex integration, revisions to sell-side EPS estimates, and macroeconomic data on Chinese demand and the Brazilian real. Shifts in any of these could push the target higher or, more plausibly, lead to downward revisions.

AI Daily Buy/Sell Signals

For traders seeking a systematic way to track changing conditions, Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on evolving market behavior, technical patterns, and AI-driven analysis. Rather than replacing fundamental research, the tool helps investors discover opportunities, monitor existing positions, and identify shifting trends more efficiently. Explore the AI Daily Buy/Sell Signals to see how automated signals can complement your own analysis of names like Suzano.

Final Assessment

The $13.20 target is a real but thinly sourced figure — the average of two current U.S. analyst targets, $13.00 and $13.40. From roughly $8.45, it implies about 56% upside, a very large move that would require a confirmed pulp-price upcycle, earnings stabilization, and meaningful multiple expansion. The supportive case rests on recovering prices, cost leadership, and the Arbex diversification, while leverage, declining EPS estimates, and currency and China demand risks present genuine obstacles. The wide gap between a modest near-$8.50 share price and a $13-plus objective underscores both the opportunity and the uncertainty. Investors should monitor the November earnings report, pulp-price announcements, and analyst revisions rather than treat the target as a forecast.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations